You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PROCAINE MERETHOXYLLINE; THEOPHYLLINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for procaine merethoxylline; theophylline and what is the scope of patent protection?

Procaine merethoxylline; theophylline is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for PROCAINE MERETHOXYLLINE; THEOPHYLLINE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
DailyMed Link:PROCAINE MERETHOXYLLINE; THEOPHYLLINE at DailyMed

US Patents and Regulatory Information for PROCAINE MERETHOXYLLINE; THEOPHYLLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly DICURIN PROCAINE procaine merethoxylline; theophylline INJECTABLE;INJECTION 008869-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

PROCAINE MERETHOXYLLINE; THEOPHYLLINE Market Analysis and Financial Projection Experimental

Procaine: Market Dynamics and Financial Trajectory

Introduction

Procaine, a local anesthetic discovered in 1905, has a diverse range of applications in medical, cosmetic, and veterinary fields. This article will delve into the market dynamics and financial trajectory of procaine, focusing on its various uses, market trends, and future prospects.

Historical Context and Medical Applications

Procaine has been a cornerstone in medical practices for over a century, primarily used as a local anesthetic in dental procedures and minor surgeries. Its efficacy in numbing pain has made it an essential tool in outpatient and minor surgical settings, reducing the need for complex anesthetic procedures[2].

Market Size and Growth

The procaine market was valued at USD 21.4 billion in 2023 and is projected to reach USD 30.5 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.6%. This growth is driven by the rising demand for pain management solutions, advancements in drug formulations, and expanding access to healthcare in emerging markets[2].

Key Drivers of Market Growth

Rising Demand for Pain Management

The increasing prevalence of medical and cosmetic procedures has heightened the demand for effective pain management solutions. Procaine's role in reducing discomfort during these procedures makes it a critical component of healthcare systems globally[2].

Advancements in Drug Formulations

Recent innovations have focused on improving the bioavailability and efficacy of procaine. Sustained-release formulations and combination therapies are being developed to enhance patient outcomes and extend its use in complex medical scenarios. These advancements have positioned the procaine market as a significant growth area in the pharmaceutical industry[2].

Expanding Access to Healthcare

Emerging markets, particularly in the Asia-Pacific and Africa regions, are witnessing improved healthcare infrastructure and increased awareness about pain management solutions. This expansion has created significant opportunities for the procaine market to grow[2].

Diverse Applications of Procaine

Medical Applications

Procaine is widely used in dental procedures and minor surgeries. It also has applications in cancer therapy, where it acts as a DNA-demethylating agent, inhibiting tumor growth by reactivating epigenetically silenced genes[1].

Cosmetic Applications

In the cosmetic sector, procaine is used to reduce discomfort during invasive procedures. Its anesthetic properties make it a preferred choice for minimizing pain in cosmetic treatments[2].

Veterinary Medicine

Procaine is also utilized in veterinary medicine to ensure humane treatment for animals by providing effective pain relief during medical procedures[2].

Financial Trajectory

Investment Opportunities

The procaine market offers lucrative investment opportunities, particularly in Research and Development (R&D), emerging markets, and sustainable manufacturing processes. Strategic partnerships and collaborations have accelerated innovation, addressing unmet medical needs and expanding product portfolios[2].

Economic Importance

The procaine market contributes significantly to the global pharmaceutical industry. The rising healthcare expenditure and increasing demand for cosmetic procedures have driven its economic importance. Innovations in drug delivery systems and sustained-release formulations further enhance its market value[2].

Procaine Merethoxylline and Theophylline: Specific Considerations

While procaine itself is a well-established drug, specific formulations like procaine merethoxylline and theophylline have unique considerations:

Procaine Merethoxylline

This formulation, although not widely discussed in recent literature, would typically follow the broader trends of the procaine market. However, its specific application and market dynamics might be influenced by its combination with other drugs and its targeted therapeutic uses.

Theophylline

Theophylline, often used in combination with other drugs, has its own market dynamics. When combined with procaine, the financial trajectory would be influenced by the synergistic effects of both drugs. However, the specific combination of procaine merethoxylline and theophylline has been withdrawn, indicating that this particular formulation may not be a significant contributor to the current market growth[4].

Future Prospects

The procaine market is poised for sustained growth, driven by increasing demand for effective pain management solutions and ongoing innovations in drug development. As healthcare systems worldwide prioritize patient comfort and accessibility, the market's significance will continue to grow.

Emerging Markets

Countries in the Asia-Pacific and Africa regions are emerging as key growth hubs, providing significant opportunities for market expansion. Improved healthcare infrastructure and increased awareness about pain management solutions in these regions will drive the market forward[2].

Innovations and R&D

Investments in R&D are leading to the discovery of new applications for procaine, expanding its market potential. Companies are exploring its use in combination with other drugs to address complex medical conditions, further enhancing its therapeutic value[2].

Key Takeaways

  • The procaine market is valued at USD 21.4 billion in 2023 and is expected to reach USD 30.5 billion by 2031.
  • Key drivers include rising demand for pain management, advancements in drug formulations, and expanding access to healthcare in emerging markets.
  • Procaine has diverse applications in medical, cosmetic, and veterinary fields.
  • The market offers lucrative investment opportunities in R&D, emerging markets, and sustainable manufacturing processes.
  • Innovations in drug delivery systems and combination therapies are enhancing the market's growth potential.

FAQs

What is the primary use of procaine in medical practices?

Procaine is primarily used as a local anesthetic in dental procedures and minor surgeries to numb pain and reduce discomfort.

How is the procaine market expected to grow in the future?

The procaine market is expected to grow at a CAGR of 4.6% from 2023 to 2031, reaching a value of USD 30.5 billion by 2031.

What are the key drivers of the procaine market growth?

The key drivers include the rising demand for pain management solutions, advancements in drug formulations, and expanding access to healthcare in emerging markets.

What are some of the non-medical applications of procaine?

Procaine is used in cosmetic treatments to reduce discomfort during invasive procedures and in veterinary medicine to ensure humane treatment for animals.

Why is procaine considered a promising candidate for cancer therapy?

Procaine acts as a DNA-demethylating agent, inhibiting tumor growth by reactivating epigenetically silenced genes, making it a promising candidate for future cancer therapies based on epigenetics[1].

References

  1. Procaine Is a DNA-demethylating Agent with Growth-inhibitory Effects in Breast Cancer Cells. Cancer Research, 2003.
  2. Procaine Market Gains Momentum Amid Rising Demand in Medical and Cosmetic Applications. Market Research Intellect, 2024.
  3. Price and Quality in the Generic Pharmaceutical Market. PubMed, 2022.
  4. Eli Lilly & Co. Ltd. - Synapse - Global Drug Intelligence Database. Synapse.
  5. Procaine–The Controversial Geroprotector Candidate: New Insights Regarding Its Molecular and Cellular Effects. Wiley Online Library, 2021.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.